Eppley Limited (JMSE:EPLY)

CTI BioPharma Statistics

Total Valuation

Eppley has a market cap or net worth of JMD 6.50 billion.

Market Cap	6.50B
Enterprise Value	n/a

Important Dates

Earnings Date	n/a
Ex-Dividend Date	May 30, 2025

Share Statistics

Eppley has 195.00 million shares outstanding.

Current Share Class	195.00M
Shares Outstanding	195.00M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	16.78%
Owned by Institutions (%)	0.60%
Float	33.21M

Valuation Ratios

The trailing PE ratio is 6.44.

PE Ratio	6.44
Forward PE	n/a
PS Ratio	9.12
PB Ratio	0.61
P/TBV Ratio	3.19
P/FCF Ratio	15.91
P/OCF Ratio	7.01
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 231.81, with a Debt / Equity ratio of 0.87.

Current Ratio	231.81
Quick Ratio	191.50
Debt / Equity	0.87
Debt / EBITDA	n/a
Debt / FCF	22.80
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is 26.11%.

Return on Equity (ROE)	26.11%
Return on Assets (ROA)	12.01%
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	n/a
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.05
Inventory Turnover	n/a

Taxes

In the past 12 months, Eppley has paid 57.10 million in taxes.

Income Tax	57.10M
Effective Tax Rate	3.35%

Stock Price Statistics

The stock price has decreased by -12.32% in the last 52 weeks. The beta is 0.19, so Eppley's price volatility has been lower than the market average.

Beta (5Y)	0.19
52-Week Price Change	-12.32%
50-Day Moving Average	32.42
200-Day Moving Average	33.76
Relative Strength Index (RSI)	54.53
Average Volume (20 Days)	831

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Eppley had revenue of JMD 712.25 million and earned 995.25 million in profits. Earnings per share was 5.17.

Revenue	712.25M
Gross Profit	704.67M
Operating Income	233.00M
Pretax Income	1.71B
Net Income	995.25M
EBITDA	n/a
EBIT	n/a
Earnings Per Share (EPS)	5.17

Balance Sheet

The company has 1.22 billion in cash and 9.31 billion in debt, giving a net cash position of -8.09 billion or -41.48 per share.

Cash & Cash Equivalents	1.22B
Total Debt	9.31B
Net Cash	-8.09B
Net Cash Per Share	-41.48
Equity (Book Value)	10.68B
Book Value Per Share	10.44
Working Capital	5.17B

Cash Flow

In the last 12 months, operating cash flow was 927.38 million and capital expenditures -518.87 million, giving a free cash flow of 408.51 million.

Operating Cash Flow	927.38M
Capital Expenditures	-518.87M
Free Cash Flow	408.51M
FCF Per Share	2.09

Margins

Gross margin is 98.94%, with operating and profit margins of 32.71% and 139.73%.

Gross Margin	98.94%
Operating Margin	32.71%
Pretax Margin	239.52%
Profit Margin	139.73%
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	57.35%

Dividends & Yields

This stock pays an annual dividend of 1.20, which amounts to a dividend yield of 3.68%.

Dividend Per Share	1.20
Dividend Yield	3.68%
Dividend Growth (YoY)	-6.03%
Years of Dividend Growth	1
Payout Ratio	41.58%
Buyback Yield	n/a
Shareholder Yield	3.68%
Earnings Yield	15.32%
FCF Yield	6.29%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on November 28, 2016. It was a forward split with a ratio of 150.

Last Split Date	Nov 28, 2016
Split Type	Forward
Split Ratio	150

Scores

Altman Z-Score	n/a
Piotroski F-Score	3